The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi.
Chagas disease, caused by Trypanosoma cruzi, is a neglected tropical disease that affects 5-6 million people in endemic areas of the Americas. Presently, chemotherapy relies on two compounds that were proposed as trypanocidal drugs four decades ago: nifurtimox and benznidazole. Both drugs are able t...
Saved in:
Main Authors: | Higo Fernando Santos Souza (Author), Sandra Carla Rocha (Author), Flávia Silva Damasceno (Author), Ludmila Nakamura Rapado (Author), Elisabeth Mieko Furusho Pral (Author), Claudio Romero Farias Marinho (Author), Ariel Mariano Silber (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Memantine, an antagonist of the NMDA glutamate receptor, affects cell proliferation, differentiation and the intracellular cycle and induces apoptosis in Trypanosoma cruzi.
by: Flávia Silva Damasceno, et al.
Published: (2014) -
The glutamine synthetase of Trypanosoma cruzi is required for its resistance to ammonium accumulation and evasion of the parasitophorous vacuole during host-cell infection.
by: Marcell Crispim, et al.
Published: (2018) -
The Trypanosoma cruzi Protein TcHTE Is Critical for Heme Uptake.
by: Marcelo L Merli, et al.
Published: (2016) -
Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer's Disease, in Silico Trials
by: Dariusz Świetlik, et al.
Published: (2022) -
Inducible nitric oxide inhibitors block NMDA antagonist-stimulated motoric behaviors and medial prefrontal cortical glutamate efflux
by: Hadley C Bergstrom, et al.
Published: (2015)